US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

34.61

-0.7100-2.01%

Volume:557.52K

Turnover:19.32M

Market Cap:2.42B

PE:-11.56

High:35.73

Open:35.31

Low:34.13

Close:35.32

52wk High:38.13

52wk Low:20.65

Shares:69.86M

Float Shares:43.70M

Volume Ratio:0.86

T/O Rate:1.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9943

EPS(LYR):-3.4871

ROE:-70.46%

ROA:-42.32%

PB:6.93

PE(LYR):-9.93

Loading ...

Overview Company News Filings

Press Release: Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares

Pharvaris price target raised to $31 from $30 at BofA

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)

BRIEF-Pharvaris Announces Pricing Of $115 Million Underwritten Offering Of Ordinary Shares

Pharvaris prices $115 million follow-on offering at $29.68 per share

Pharvaris Nv: Pricing of an Underwritten Offering of 3,874,664 of Its Ordinary Shares at a Price of $29.68 per Share

THOMSON REUTERS

Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares

Pharvaris CMO Lu Peng disposes of shares worth $427,111.81

Pharvaris Chief Early Development Anne Lesage disposes of shares worth $1.32 million

Pharvaris (PHVS) Valuation Check After Conference Data Support For Deucrictibant Combination Regimen

Simply Wall St.

Top Pharvaris Executive Executes Notable Insider Stock Sale

Pharvaris director Johannes Schikan disposes 7,100 shares for $213,678.70

Pharvaris Chief Early Development Anne Lesage disposes of USD 225,511 common shares

Pharvaris Chief Medical Officer Lu Peng disposes of common shares worth $213,411

Is Evidence Backing Dual Deucrictibant Use Altering The Investment Case For Pharvaris (PHVS)?

Simply Wall St.

Pharvaris presents data from deucrictibant IR capsule and XR tablet study

Pharvaris data support combining deucrictibant XR prophylaxis with IR dosing for breakthrough attacks

Pharvaris price target raised to $52 from $48 at JonesResearch

Pharvaris Initiated at Outperform by Wolfe Research

Morgan Stanley Sticks to Their Buy Rating for Pharvaris (PHVS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PHVS/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","market":"US","secType":"STK","nameCN":"Pharvaris N.V.","latestPrice":34.61,"timestamp":1788206400000,"preClose":35.32,"halted":0,"volume":557515,"delay":0,"changeRate":-0.02010192525481316,"floatShares":43698700,"shares":69863685,"eps":-2.994346,"marketStatus":"Pre-Mkt","change":-0.71,"latestTime":"09-01 04:14:53 EDT","open":35.31,"high":35.7275,"low":34.13,"amount":19317965.554405,"amplitude":0.045229,"askPrice":39.37,"askSize":1,"bidPrice":33.63,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-2.994346,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":34.61,"postHourTrading":{"tag":"盘后","latestPrice":34.61,"preClose":34.61,"latestTime":"19:30 EDT","volume":73431,"amount":2541448.847004,"timestamp":1788219002740,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.858768,"impliedVol":1.1771,"impliedVolPercentile":0.9296},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","floatShares":43698700,"roa":"-42.32%","roe":"-70.46%","lyrEps":-3.487143,"volumeRatio":0.858768,"shares":69863685,"dividePrice":0,"high":35.7275,"amplitude":0.045229,"preClose":35.32,"low":34.13,"week52Low":20.65,"pbRate":"6.93","week52High":38.13,"institutionHeld":0,"latestPrice":34.61,"committee":0.993355,"eps":-2.994346,"divideRate":0,"volume":557515,"delay":0,"ttmEps":-2.994346,"open":35.31,"prevYearClose":27.75,"prevWeekClose":35.32,"prevMonthClose":32.62,"prevQuarterClose":34.58,"fiveDayClose":37.31,"twentyDayClose":32.25,"sixtyDayClose":31.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHVS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"PHVS","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.81},{"market":"US","date":"2026-05-12","symbol":"PHVS","fiscalQuarterEnding":"2026/03","expectedEps":-0.76,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.7},{"market":"US","date":"2026-04-02","symbol":"PHVS","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1775102400000,"reportTimeType":"pre","actualEps":-0.84},{"market":"US","date":"2025-11-12","symbol":"PHVS","fiscalQuarterEnding":"2025/09","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-08-12","symbol":"PHVS","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.94}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHVS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHVS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4667,"buy":0.4667,"hold":0.0667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4667,"analysts":15,"updateTime":1784347200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHVS","date":"2026-08-28","current":-11.55845,"percent":0.118324,"low":-16.528573,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"high":-1.271834,"avg":-8.831099,"sd":3.174243,"marketCap":2597566722},"quantilePoints":[{"date":"2021-09-03","current":-13.869765,"twenty":-41.690069,"median":-21.159134,"eighty":-14.206363,"marketCap":629774552},{"date":"2021-09-10","current":-14.483783,"twenty":-41.636401,"median":-21.097683,"eighty":-14.200739,"marketCap":654620997},{"date":"2021-09-17","current":-13.408551,"twenty":-41.415194,"median":-19.619941,"eighty":-14.095163,"marketCap":601399913},{"date":"2021-09-24","current":-13.735189,"twenty":-41.105195,"median":-19.412718,"eighty":-13.917369,"marketCap":614535400},{"date":"2021-10-01","current":-13.275187,"twenty":-41.073352,"median":-19.361573,"eighty":-13.752501,"marketCap":588032525},{"date":"2021-10-08","current":-11.567624,"twenty":-40.951984,"median":-19.206349,"eighty":-13.609193,"marketCap":511505475},{"date":"2021-10-15","current":-11.808567,"twenty":-40.76486,"median":-19.158657,"eighty":-13.358075,"marketCap":523431769},{"date":"2021-10-22","current":-11.367098,"twenty":-40.543106,"median":-18.996962,"eighty":-13.26419,"marketCap":505211043},{"date":"2021-10-29","current":-13.069107,"twenty":-40.31092,"median":-18.615071,"eighty":-13.235325,"marketCap":577431375},{"date":"2021-11-05","current":-11.318661,"twenty":-40.118706,"median":-18.174436,"eighty":-12.989342,"marketCap":499744825},{"date":"2021-11-12","current":-12.526544,"twenty":-39.882961,"median":-18.037659,"eighty":-12.809718,"marketCap":547946928},{"date":"2021-11-19","current":-11.924212,"twenty":-39.73926,"median":-17.467833,"eighty":-12.433857,"marketCap":515812193},{"date":"2021-11-26","current":-10.362749,"twenty":-39.575288,"median":-16.707882,"eighty":-12.294384,"marketCap":448064220},{"date":"2021-12-03","current":-11.26034,"twenty":-38.958466,"median":-15.822297,"eighty":-12.166304,"marketCap":485665173},{"date":"2021-12-10","current":-11.449501,"twenty":-38.90261,"median":-15.106412,"eighty":-12.085176,"marketCap":494941179},{"date":"2021-12-17","current":-11.918983,"twenty":-38.786622,"median":-14.824901,"eighty":-12.032102,"marketCap":513493191},{"date":"2021-12-23","current":-12.067526,"twenty":-38.613439,"median":-14.809703,"eighty":-12.04158,"marketCap":521775339},{"date":"2021-12-31","current":-10.970608,"twenty":-38.556139,"median":-14.6624,"eighty":-12.029733,"marketCap":476720453},{"date":"2022-01-07","current":-14.755715,"twenty":-38.260176,"median":-14.556631,"eighty":-12.04158,"marketCap":639381844},{"date":"2022-01-14","current":-13.648303,"twenty":-37.900499,"median":-14.301086,"eighty":-12.059144,"marketCap":595652102},{"date":"2022-01-21","current":-13.462107,"twenty":-37.887735,"median":-14.301086,"eighty":-12.06585,"marketCap":583394522},{"date":"2022-01-28","current":-13.205088,"twenty":-37.172324,"median":-14.201073,"eighty":-12.067932,"marketCap":563186081},{"date":"2022-02-04","current":-13.024782,"twenty":-36.626254,"median":-14.120681,"eighty":-12.079807,"marketCap":569480513},{"date":"2022-02-11","current":-13.759795,"twenty":-36.368387,"median":-14.065459,"eighty":-12.092451,"marketCap":599627533},{"date":"2022-02-18","current":-13.388638,"twenty":-36.150333,"median":-14.023379,"eighty":-12.098608,"marketCap":579750377},{"date":"2022-02-25","current":-13.305926,"twenty":-35.845851,"median":-13.954525,"eighty":-12.116084,"marketCap":572793372},{"date":"2022-03-04","current":-14.115965,"twenty":-35.670778,"median":-13.938377,"eighty":-12.137788,"marketCap":588695097},{"date":"2022-03-11","current":-13.463028,"twenty":-34.421493,"median":-13.892451,"eighty":-12.149516,"marketCap":563186081},{"date":"2022-03-18","current":-14.218002,"twenty":-29.632768,"median":-13.881977,"eighty":-12.157248,"marketCap":600952677},{"date":"2022-03-25","current":-13.943073,"twenty":-26.658074,"median":-13.883771,"eighty":-12.178203,"marketCap":585382238},{"date":"2022-04-01","current":-12.747151,"twenty":-26.362243,"median":-13.880091,"eighty":-12.194172,"marketCap":601209361},{"date":"2022-04-08","current":-13.160374,"twenty":-26.219887,"median":-13.869765,"eighty":-12.198767,"marketCap":611652204},{"date":"2022-04-14","current":-12.64181,"twenty":-26.010325,"median":-13.786628,"eighty":-12.200601,"marketCap":583804624},{"date":"2022-04-22","current":-12.23556,"twenty":-25.770465,"median":-13.764494,"eighty":-12.203958,"marketCap":563581977},{"date":"2022-04-29","current":-12.580911,"twenty":-25.660418,"median":-13.730786,"eighty":-12.217679,"marketCap":566542439},{"date":"2022-05-06","current":-12.310085,"twenty":-25.093495,"median":-13.707219,"eighty":-12.233824,"marketCap":557283119},{"date":"2022-05-13","current":-10.422165,"twenty":-24.148325,"median":-13.655613,"eighty":-12.198139,"marketCap":571878572},{"date":"2022-05-20","current":-10.134271,"twenty":-23.650401,"median":-13.608097,"eighty":-12.152353,"marketCap":563590477},{"date":"2022-05-27","current":-10.266885,"twenty":-23.509475,"median":-13.570194,"eighty":-12.096742,"marketCap":579835143},{"date":"2022-06-03","current":-10.984203,"twenty":-23.463638,"median":-13.4682,"eighty":-12.07039,"marketCap":620612572},{"date":"2022-06-10","current":-12.843347,"twenty":-23.155882,"median":-13.459721,"eighty":-12.067627,"marketCap":712444667},{"date":"2022-06-17","current":-16.528573,"twenty":-22.410251,"median":-13.457335,"eighty":-12.07039,"marketCap":911690477},{"date":"2022-06-24","current":-12.484354,"twenty":-22.307498,"median":-13.442896,"eighty":-12.079819,"marketCap":694210858},{"date":"2022-07-01","current":-14.299351,"twenty":-21.874535,"median":-13.402807,"eighty":-12.068033,"marketCap":784053810},{"date":"2022-07-08","current":-14.094213,"twenty":-21.750061,"median":-13.450115,"eighty":-12.077462,"marketCap":756209125},{"date":"2022-07-15","current":-14.396825,"twenty":-21.331431,"median":-13.463028,"eighty":-12.082165,"marketCap":765820001},{"date":"2022-07-22","current":-13.29424,"twenty":-21.174218,"median":-13.473474,"eighty":-12.092451,"marketCap":716422953},{"date":"2022-07-29","current":-13.469033,"twenty":-21.125909,"median":-13.4682,"eighty":-12.098608,"marketCap":724213762},{"date":"2022-08-05","current":-11.76507,"twenty":-21.101667,"median":-13.459721,"eighty":-12.082165,"marketCap":629895239},{"date":"2022-08-12","current":-10.43948,"twenty":-20.186916,"median":-13.408551,"eighty":-12.055631,"marketCap":564253524},{"date":"2022-08-19","current":-11.581834,"twenty":-19.826532,"median":-13.395996,"eighty":-12.028713,"marketCap":612987524},{"date":"2022-08-26","current":-5.820227,"twenty":-19.515891,"median":-13.372919,"eighty":-11.990749,"marketCap":306659524},{"date":"2022-09-02","current":-5.892736,"twenty":-19.429171,"median":-13.356682,"eighty":-11.943475,"marketCap":311632381},{"date":"2022-09-09","current":-5.834763,"twenty":-19.417564,"median":-13.345814,"eighty":-11.915113,"marketCap":308814429},{"date":"2022-09-16","current":-6.129031,"twenty":-19.393433,"median":-13.317212,"eighty":-11.844209,"marketCap":307945619},{"date":"2022-09-23","current":-5.527907,"twenty":-19.377706,"median":-13.304479,"eighty":-11.805952,"marketCap":269452416},{"date":"2022-09-30","current":-5.268219,"twenty":-19.358729,"median":-13.29424,"eighty":-11.739355,"marketCap":258984966},{"date":"2022-10-07","current":-3.334511,"twenty":-19.313349,"median":-13.281408,"eighty":-11.574558,"marketCap":163427280},{"date":"2022-10-14","current":-3.192899,"twenty":-19.240081,"median":-13.26552,"eighty":-11.519941,"marketCap":155998767},{"date":"2022-10-21","current":-3.776992,"twenty":-19.189017,"median":-13.2607,"eighty":-11.419826,"marketCap":185712818},{"date":"2022-10-28","current":-3.404363,"twenty":-19.175941,"median":-13.241782,"eighty":-11.34035,"marketCap":169704373},{"date":"2022-11-04","current":-2.493588,"twenty":-19.155403,"median":-13.21909,"eighty":-11.293284,"marketCap":123921098},{"date":"2022-11-11","current":-1.962841,"twenty":-19.119693,"median":-13.202703,"eighty":-11.220822,"marketCap":101635560},{"date":"2022-11-18","current":-1.709372,"twenty":-19.040002,"median":-13.169144,"eighty":-11.073401,"marketCap":88804493},{"date":"2022-11-25","current":-1.59989,"twenty":-18.960552,"median":-13.089194,"eighty":-10.924331,"marketCap":83401938},{"date":"2022-12-02","current":-1.271834,"twenty":-18.879299,"median":-13.066255,"eighty":-10.549888,"marketCap":66856614},{"date":"2022-12-09","current":-5.585763,"twenty":-18.659925,"median":-13.055482,"eighty":-10.38824,"marketCap":291250318},{"date":"2022-12-16","current":-4.830297,"twenty":-18.384979,"median":-13.024782,"eighty":-10.32247,"marketCap":253408050},{"date":"2022-12-23","current":-6.371604,"twenty":-18.295522,"median":-12.990589,"eighty":-10.187317,"marketCap":334836503},{"date":"2022-12-30","current":-7.188594,"twenty":-18.170479,"median":-12.982972,"eighty":-10.008759,"marketCap":380112075},{"date":"2023-01-06","current":-7.688928,"twenty":-18.154652,"median":-12.903124,"eighty":-9.752954,"marketCap":403763493},{"date":"2023-01-13","current":-5.706058,"twenty":-18.104257,"median":-12.846213,"eighty":-7.688928,"marketCap":305441169},{"date":"2023-01-20","current":-6.459312,"twenty":-17.9977,"median":-12.837332,"eighty":-7.374204,"marketCap":346324335},{"date":"2023-01-27","current":-5.951135,"twenty":-17.857094,"median":-12.821298,"eighty":-6.862976,"marketCap":319632020},{"date":"2023-02-03","current":-5.776873,"twenty":-17.539987,"median":-12.756949,"eighty":-6.367933,"marketCap":310171453},{"date":"2023-02-10","current":-6.06212,"twenty":-17.052096,"median":-12.693639,"eighty":-6.243368,"marketCap":320307775},{"date":"2023-02-17","current":-5.565251,"twenty":-16.755938,"median":-12.64181,"eighty":-6.151395,"marketCap":293615460},{"date":"2023-02-24","current":-5.080906,"twenty":-16.600297,"median":-12.612561,"eighty":-6.08797,"marketCap":265233759},{"date":"2023-03-03","current":-5.604926,"twenty":-16.439572,"median":-12.581052,"eighty":-6.019199,"marketCap":293953338},{"date":"2023-03-10","current":-4.059398,"twenty":-16.126823,"median":-12.554737,"eighty":-5.957727,"marketCap":214214271},{"date":"2023-03-17","current":-4.759844,"twenty":-15.898426,"median":-12.5386,"eighty":-5.915214,"marketCap":251042908},{"date":"2023-03-24","current":-4.748457,"twenty":-15.814998,"median":-12.484354,"eighty":-5.839251,"marketCap":252732295},{"date":"2023-03-31","current":-5.062872,"twenty":-15.558556,"median":-12.41617,"eighty":-5.818726,"marketCap":272160245},{"date":"2023-04-06","current":-5.515395,"twenty":-15.2868,"median":-12.393076,"eighty":-5.798276,"marketCap":298007866},{"date":"2023-04-14","current":-3.407139,"twenty":-15.104598,"median":-12.376683,"eighty":-5.751686,"marketCap":287439901},{"date":"2023-04-21","current":-3.423024,"twenty":-15.075219,"median":-12.365371,"eighty":-5.695738,"marketCap":286594490},{"date":"2023-04-28","current":-3.621546,"twenty":-14.971826,"median":-12.310085,"eighty":-5.661512,"marketCap":304686295},{"date":"2023-05-05","current":-3.635585,"twenty":-14.858222,"median":-12.26867,"eighty":-5.593428,"marketCap":305362624},{"date":"2023-05-12","current":-3.330904,"twenty":-14.826016,"median":-12.249364,"eighty":-5.568587,"marketCap":277633128},{"date":"2023-05-19","current":-3.332274,"twenty":-14.818952,"median":-12.234113,"eighty":-5.5204,"marketCap":297584839},{"date":"2023-05-26","current":-3.231497,"twenty":-14.811441,"median":-12.222059,"eighty":-5.439393,"marketCap":287439901},{"date":"2023-06-02","current":-3.434585,"twenty":-14.791955,"median":-12.201472,"eighty":-5.312927,"marketCap":305832502},{"date":"2023-06-09","current":-3.407273,"twenty":-14.764775,"median":-12.198453,"eighty":-5.28475,"marketCap":304479261},{"date":"2023-06-16","current":-4.170938,"twenty":-14.740265,"median":-12.160354,"eighty":-5.07843,"marketCap":377892593},{"date":"2023-06-23","current":-4.359744,"twenty":-14.731325,"median":-12.152393,"eighty":-5.057591,"marketCap":396297439},{"date":"2023-06-30","current":-7.00064,"twenty":-14.718305,"median":-12.136009,"eighty":-5.055831,"marketCap":632126719},{"date":"2023-07-07","current":-7.084548,"twenty":-14.696694,"median":-12.097209,"eighty":-5.062872,"marketCap":638244074},{"date":"2023-07-14","current":-6.875228,"twenty":-14.6624,"median":-12.079819,"eighty":-5.068525,"marketCap":638244074},{"date":"2023-07-21","current":-7.028003,"twenty":-14.653302,"median":-12.064139,"eighty":-5.080906,"marketCap":649663138},{"date":"2023-07-28","current":-7.498848,"twenty":-14.622905,"median":-12.04158,"eighty":-5.207419,"marketCap":683512504},{"date":"2023-08-04","current":-7.953511,"twenty":-14.601036,"median":-12.024634,"eighty":-5.228713,"marketCap":722255754},{"date":"2023-08-11","current":-7.354477,"twenty":-14.583407,"median":-11.998532,"eighty":-5.261383,"marketCap":747059362},{"date":"2023-08-18","current":-7.862758,"twenty":-14.572779,"median":-11.956319,"eighty":-5.28475,"marketCap":788698737},{"date":"2023-08-25","current":-7.637624,"twenty":-14.506463,"median":-11.943194,"eighty":-5.298861,"marketCap":762796904},{"date":"2023-08-31","current":-8.133422,"twenty":-14.4867,"median":-11.921598,"eighty":-5.305964,"marketCap":813459365},{"date":"2023-09-08","current":-7.866907,"twenty":-14.484166,"median":-11.909309,"eighty":-5.312927,"marketCap":776279656},{"date":"2023-09-15","current":-8.565073,"twenty":-14.483879,"median":-11.869315,"eighty":-5.324599,"marketCap":842467710},{"date":"2023-09-22","current":-8.218785,"twenty":-14.422991,"median":-11.843691,"eighty":-5.364732,"marketCap":808147978},{"date":"2023-09-29","current":-8.499622,"twenty":-14.407261,"median":-11.810464,"eighty":-5.391254,"marketCap":828167822},{"date":"2023-10-06","current":-8.075664,"twenty":-14.404891,"median":-11.805298,"eighty":-5.421144,"marketCap":784042452},{"date":"2023-10-13","current":-7.97887,"twenty":-14.393189,"median":-11.762441,"eighty":-5.494747,"marketCap":776279656},{"date":"2023-10-20","current":-7.871535,"twenty":-14.374592,"median":-11.67635,"eighty":-5.497417,"marketCap":767699722},{"date":"2023-10-27","current":-7.699507,"twenty":-14.37054,"median":-11.628617,"eighty":-5.497654,"marketCap":747679879},{"date":"2023-11-03","current":-7.17043,"twenty":-14.351862,"median":-11.573402,"eighty":-5.505177,"marketCap":701920236},{"date":"2023-11-10","current":-5.970942,"twenty":-14.325681,"median":-11.546094,"eighty":-5.518658,"marketCap":686476556},{"date":"2023-11-17","current":-5.487665,"twenty":-14.300392,"median":-11.499199,"eighty":-5.518658,"marketCap":639755166},{"date":"2023-11-24","current":-5.931936,"twenty":-14.283081,"median":-11.456561,"eighty":-5.501771,"marketCap":694263454},{"date":"2023-12-01","current":-6.025826,"twenty":-14.216157,"median":-11.367098,"eighty":-5.517027,"marketCap":705329046},{"date":"2023-12-08","current":-11.439876,"twenty":-14.20757,"median":-11.347894,"eighty":-5.524424,"marketCap":1324602518},{"date":"2023-12-15","current":-11.41059,"twenty":-14.202076,"median":-11.375314,"eighty":-5.532271,"marketCap":1346488162},{"date":"2023-12-22","current":-11.925452,"twenty":-14.184853,"median":-11.42744,"eighty":-5.551316,"marketCap":1406934225},{"date":"2023-12-29","current":-12.247032,"twenty":-14.141201,"median":-11.449501,"eighty":-5.556079,"marketCap":1455916379},{"date":"2024-01-05","current":-11.217845,"twenty":-14.124263,"median":-11.444688,"eighty":-5.560701,"marketCap":1319391651},{"date":"2024-01-12","current":-13.194311,"twenty":-14.118795,"median":-11.460366,"eighty":-5.568587,"marketCap":1550325393},{"date":"2024-01-19","current":-14.465426,"twenty":-14.174814,"median":-11.47464,"eighty":-5.574125,"marketCap":1686754028},{"date":"2024-01-26","current":-14.983944,"twenty":-14.20757,"median":-11.499199,"eighty":-5.577066,"marketCap":1742861042},{"date":"2024-02-02","current":-15.192524,"twenty":-14.300739,"median":-11.528223,"eighty":-5.581389,"marketCap":1768847449},{"date":"2024-02-09","current":-14.748842,"twenty":-14.393189,"median":-11.54682,"eighty":-5.589596,"marketCap":1703881432},{"date":"2024-02-16","current":-13.65194,"twenty":-14.404891,"median":-11.567624,"eighty":-5.608959,"marketCap":1576311800},{"date":"2024-02-23","current":-14.13304,"twenty":-14.396825,"median":-11.581834,"eighty":-5.625092,"marketCap":1640687216},{"date":"2024-03-01","current":-10.303743,"twenty":-14.378644,"median":-11.573402,"eighty":-5.629721,"marketCap":1195373004},{"date":"2024-03-08","current":-12.093153,"twenty":-14.358385,"median":-11.567624,"eighty":-5.636181,"marketCap":1418455194},{"date":"2024-03-15","current":-10.896325,"twenty":-14.342077,"median":-11.552539,"eighty":-5.658684,"marketCap":1273758779},{"date":"2024-03-22","current":-11.538805,"twenty":-14.301086,"median":-11.546205,"eighty":-5.665753,"marketCap":1344762225},{"date":"2024-03-28","current":-10.904189,"twenty":-14.299698,"median":-11.538805,"eighty":-5.674035,"marketCap":1264076491},{"date":"2024-04-05","current":-10.349243,"twenty":-14.288877,"median":-11.507756,"eighty":-5.680711,"marketCap":1206520668},{"date":"2024-04-12","current":-11.107813,"twenty":-14.231653,"median":-11.490879,"eighty":-5.687459,"marketCap":1200065809},{"date":"2024-04-19","current":-9.215802,"twenty":-14.210621,"median":-11.46913,"eighty":-5.702618,"marketCap":991303742},{"date":"2024-04-26","current":-11.339937,"twenty":-14.20395,"median":-11.459096,"eighty":-5.715476,"marketCap":1225406418},{"date":"2024-05-03","current":-11.733497,"twenty":-14.200071,"median":-11.46913,"eighty":-5.724599,"marketCap":1266307115},{"date":"2024-05-10","current":-9.668623,"twenty":-14.189365,"median":-11.459096,"eighty":-5.733174,"marketCap":1107009662},{"date":"2024-05-17","current":-10.115404,"twenty":-14.156013,"median":-11.42744,"eighty":-5.759289,"marketCap":1168360708},{"date":"2024-05-24","current":-9.147602,"twenty":-14.136092,"median":-11.375314,"eighty":-5.774576,"marketCap":1052116621},{"date":"2024-05-31","current":-8.827191,"twenty":-14.129207,"median":-11.35501,"eighty":-5.782121,"marketCap":1017135762},{"date":"2024-06-07","current":-7.823819,"twenty":-14.123069,"median":-11.339823,"eighty":-5.787829,"marketCap":904658844},{"date":"2024-06-14","current":-8.515887,"twenty":-14.119026,"median":-11.316994,"eighty":-5.792437,"marketCap":974082396},{"date":"2024-06-21","current":-8.52603,"twenty":-14.116428,"median":-11.288753,"eighty":-5.797709,"marketCap":970853394},{"date":"2024-06-28","current":-8.52006,"twenty":-14.116197,"median":-11.262481,"eighty":-5.798843,"marketCap":969238893},{"date":"2024-07-05","current":-7.963908,"twenty":-14.11303,"median":-11.251924,"eighty":-5.805313,"marketCap":914884019},{"date":"2024-07-12","current":-8.497692,"twenty":-14.104041,"median":-11.224936,"eighty":-5.814579,"marketCap":981616735},{"date":"2024-07-15","current":-8.709438,"twenty":-14.101747,"median":-11.224715,"eighty":-5.815211,"marketCap":1010139590},{"date":"2024-08-02","current":-7.485095,"twenty":-14.099454,"median":-11.224493,"eighty":-5.815842,"marketCap":857838309},{"date":"2024-08-09","current":-7.640912,"twenty":-14.094802,"median":-11.205504,"eighty":-5.819476,"marketCap":885822997},{"date":"2024-08-16","current":-8.240501,"twenty":-14.093907,"median":-11.162588,"eighty":-5.823431,"marketCap":1032742607},{"date":"2024-08-23","current":-7.760367,"twenty":-14.048436,"median":-11.118035,"eighty":-5.826337,"marketCap":983480417},{"date":"2024-08-30","current":-7.393035,"twenty":-14.034683,"median":-11.087899,"eighty":-5.833183,"marketCap":934333400},{"date":"2024-09-06","current":-8.155019,"twenty":-14.033224,"median":-11.020127,"eighty":-5.839251,"marketCap":1031547280},{"date":"2024-09-13","current":-8.802104,"twenty":-14.027088,"median":-10.978779,"eighty":-5.849019,"marketCap":1108238229},{"date":"2024-09-20","current":-8.962749,"twenty":-13.99324,"median":-10.957045,"eighty":-5.877056,"marketCap":1139022624},{"date":"2024-09-27","current":-8.000083,"twenty":-13.961974,"median":-10.894902,"eighty":-5.894802,"marketCap":1020205660},{"date":"2024-10-04","current":-7.688355,"twenty":-13.947654,"median":-10.874176,"eighty":-5.909483,"marketCap":966197949},{"date":"2024-10-11","current":-7.725025,"twenty":-13.936046,"median":-10.812773,"eighty":-5.924083,"marketCap":962957487},{"date":"2024-10-18","current":-9.289256,"twenty":-13.925882,"median":-10.792815,"eighty":-5.928401,"marketCap":1147663858},{"date":"2024-10-25","current":-9.347449,"twenty":-13.904362,"median":-10.773913,"eighty":-5.930655,"marketCap":1151984475},{"date":"2024-10-31","current":-10.81176,"twenty":-13.888979,"median":-10.69668,"eighty":-5.935928,"marketCap":1339391232},{"date":"2024-11-08","current":-9.795031,"twenty":-13.882336,"median":-10.614452,"eighty":-5.945603,"marketCap":1205452109},{"date":"2024-11-15","current":-7.934741,"twenty":-13.880109,"median":-10.567811,"eighty":-5.951569,"marketCap":1109858461},{"date":"2024-11-22","current":-8.193559,"twenty":-13.878421,"median":-10.530141,"eighty":-5.955891,"marketCap":1136322239},{"date":"2024-11-29","current":-8.515548,"twenty":-13.874795,"median":-10.499116,"eighty":-5.962822,"marketCap":1187704999},{"date":"2024-12-06","current":-7.575701,"twenty":-13.869107,"median":-10.430822,"eighty":-5.969,"marketCap":1058630209},{"date":"2024-12-13","current":-7.438607,"twenty":-13.864864,"median":-10.405945,"eighty":-5.972,"marketCap":1031513657},{"date":"2024-12-20","current":-7.511117,"twenty":-13.847086,"median":-10.370165,"eighty":-5.976517,"marketCap":1030971326},{"date":"2024-12-27","current":-7.680726,"twenty":-13.801742,"median":-10.357252,"eighty":-5.977661,"marketCap":1057545547},{"date":"2025-01-03","current":-7.415916,"twenty":-13.792864,"median":-10.345951,"eighty":-6.00833,"marketCap":1005481766},{"date":"2025-01-10","current":-7.387777,"twenty":-13.788234,"median":-10.323543,"eighty":-6.019199,"marketCap":1005481766},{"date":"2025-01-17","current":-6.953437,"twenty":-13.781733,"median":-10.297117,"eighty":-6.023626,"marketCap":946367682},{"date":"2025-01-24","current":-7.612205,"twenty":-13.774759,"median":-10.284647,"eighty":-6.025423,"marketCap":1047783588},{"date":"2025-01-31","current":-6.977006,"twenty":-13.765434,"median":-10.25901,"eighty":-6.034301,"marketCap":961552951},{"date":"2025-02-07","current":-7.219276,"twenty":-13.753463,"median":-10.232674,"eighty":-6.052543,"marketCap":990296497},{"date":"2025-02-14","current":-6.822516,"twenty":-13.740454,"median":-10.115609,"eighty":-6.061351,"marketCap":942029033},{"date":"2025-02-21","current":-6.467941,"twenty":-13.734308,"median":-10.093087,"eighty":-6.062421,"marketCap":894846232},{"date":"2025-02-28","current":-6.133931,"twenty":-13.727465,"median":-10.02417,"eighty":-6.065143,"marketCap":843867113},{"date":"2025-03-07","current":-5.852269,"twenty":-13.71316,"median":-9.970579,"eighty":-6.049778,"marketCap":837901472},{"date":"2025-03-14","current":-6.385184,"twenty":-13.708332,"median":-9.910974,"eighty":-6.026825,"marketCap":917081805},{"date":"2025-03-21","current":-5.844642,"twenty":-13.700767,"median":-9.829627,"eighty":-6.025288,"marketCap":838443803},{"date":"2025-03-28","current":-5.916884,"twenty":-13.679442,"median":-9.795031,"eighty":-5.984934,"marketCap":844409444},{"date":"2025-04-04","current":-5.41793,"twenty":-13.665275,"median":-9.712775,"eighty":-5.969,"marketCap":792887995},{"date":"2025-04-11","current":-4.319691,"twenty":-13.654878,"median":-9.636637,"eighty":-5.953745,"marketCap":648468389},{"date":"2025-04-17","current":-4.898467,"twenty":-13.65194,"median":-9.603412,"eighty":-5.931936,"marketCap":747645908},{"date":"2025-04-25","current":-5.660159,"twenty":-13.648303,"median":-9.484661,"eighty":-5.916884,"marketCap":862626437},{"date":"2025-05-02","current":-6.426634,"twenty":-13.611466,"median":-9.396394,"eighty":-5.918352,"marketCap":972702584},{"date":"2025-05-09","current":-6.135697,"twenty":-13.604729,"median":-9.345786,"eighty":-5.927903,"marketCap":928563139},{"date":"2025-05-16","current":-5.081075,"twenty":-13.598948,"median":-9.280564,"eighty":-5.916884,"marketCap":866985889},{"date":"2025-05-23","current":-5.189286,"twenty":-13.570194,"median":-9.208581,"eighty":-5.882056,"marketCap":893142597},{"date":"2025-05-30","current":-5.256736,"twenty":-13.527456,"median":-9.173722,"eighty":-5.851134,"marketCap":911125334},{"date":"2025-06-06","current":-5.007101,"twenty":-13.509055,"median":-9.060878,"eighty":-5.837961,"marketCap":874614929},{"date":"2025-06-13","current":-5.317982,"twenty":-13.49872,"median":-8.982791,"eighty":-5.819476,"marketCap":938916836},{"date":"2025-06-20","current":-5.183436,"twenty":-13.485895,"median":-8.943559,"eighty":-5.800161,"marketCap":906765882},{"date":"2025-06-27","current":-5.465947,"twenty":-13.472919,"median":-8.879507,"eighty":-5.782121,"marketCap":975427241},{"date":"2025-07-03","current":-5.649134,"twenty":-13.4687,"median":-8.851321,"eighty":-5.729733,"marketCap":1013572441},{"date":"2025-07-11","current":-6.060959,"twenty":-13.466131,"median":-8.823918,"eighty":-5.695738,"marketCap":1080599005},{"date":"2025-07-18","current":-7.314861,"twenty":-13.46266,"median":-8.816193,"eighty":-5.710767,"marketCap":1293122259},{"date":"2025-07-25","current":-7.006501,"twenty":-13.460198,"median":-8.785147,"eighty":-5.721214,"marketCap":1257999997},{"date":"2025-08-01","current":-8.237689,"twenty":-13.451559,"median":-8.722056,"eighty":-5.729733,"marketCap":1437436162},{"date":"2025-08-08","current":-8.281316,"twenty":-13.442628,"median":-8.688191,"eighty":-5.747092,"marketCap":1469250645},{"date":"2025-08-15","current":-8.47781,"twenty":-13.428755,"median":-8.660023,"eighty":-5.769982,"marketCap":1662306709},{"date":"2025-08-22","current":-8.638654,"twenty":-13.403956,"median":-8.63053,"eighty":-5.780372,"marketCap":1688336740},{"date":"2025-08-29","current":-8.414646,"twenty":-13.396944,"median":-8.638654,"eighty":-5.787092,"marketCap":1651460863},{"date":"2025-09-05","current":-8.112917,"twenty":-13.396458,"median":-8.622065,"eighty":-5.790869,"marketCap":1589278011},{"date":"2025-09-12","current":-8.597222,"twenty":-13.393909,"median":-8.60362,"eighty":-5.797709,"marketCap":1699182587},{"date":"2025-09-19","current":-8.94501,"twenty":-13.385494,"median":-8.610019,"eighty":-5.800038,"marketCap":1774380454},{"date":"2025-09-26","current":-9.045131,"twenty":-13.370479,"median":-8.627645,"eighty":-5.80289,"marketCap":1777272680},{"date":"2025-10-03","current":-8.512022,"twenty":-13.360301,"median":-8.638654,"eighty":-5.813948,"marketCap":1676044781},{"date":"2025-10-10","current":-8.486281,"twenty":-13.357847,"median":-8.622235,"eighty":-5.817225,"marketCap":1651460863},{"date":"2025-10-17","current":-8.047023,"twenty":-13.353429,"median":-8.597222,"eighty":-5.821028,"marketCap":1580601334},{"date":"2025-10-24","current":-8.513119,"twenty":-13.347233,"median":-8.60362,"eighty":-5.824758,"marketCap":1663029766},{"date":"2025-10-31","current":-8.263348,"twenty":-13.342738,"median":-8.57038,"eighty":-5.828443,"marketCap":1608077478},{"date":"2025-11-07","current":-8.118597,"twenty":-13.33536,"median":-8.561701,"eighty":-5.835563,"marketCap":1576262995},{"date":"2025-11-14","current":-8.953433,"twenty":-13.315064,"median":-8.562935,"eighty":-5.839457,"marketCap":1754134874},{"date":"2025-11-21","current":-8.32101,"twenty":-13.306363,"median":-8.564004,"eighty":-5.842723,"marketCap":1572018786},{"date":"2025-11-28","current":-9.70873,"twenty":-13.305926,"median":-8.567726,"eighty":-5.844642,"marketCap":1843549304},{"date":"2025-12-05","current":-9.421046,"twenty":-13.303031,"median":-8.581097,"eighty":-5.846596,"marketCap":1798727281},{"date":"2025-12-12","current":-8.095034,"twenty":-13.295471,"median":-8.575738,"eighty":-5.852269,"marketCap":1557727706},{"date":"2025-12-19","current":-8.116161,"twenty":-13.29424,"median":-8.562935,"eighty":-5.853536,"marketCap":1560326085},{"date":"2025-12-26","current":-8.732727,"twenty":-13.291734,"median":-8.57038,"eighty":-5.866198,"marketCap":1684398642},{"date":"2026-01-02","current":-9.374295,"twenty":-13.28902,"median":-8.597222,"eighty":-5.876979,"marketCap":1802624848},{"date":"2026-01-09","current":-8.51177,"twenty":-13.280164,"median":-8.575738,"eighty":-5.882433,"marketCap":1623986350},{"date":"2026-01-16","current":-8.766662,"twenty":-13.272619,"median":-8.610019,"eighty":-5.888715,"marketCap":1666209995},{"date":"2026-01-23","current":-9.448662,"twenty":-13.268752,"median":-8.622065,"eighty":-5.894114,"marketCap":1817565522},{"date":"2026-01-30","current":-9.241158,"twenty":-13.264633,"median":-8.634183,"eighty":-5.904462,"marketCap":1805223226},{"date":"2026-02-06","current":-8.459688,"twenty":-13.260074,"median":-8.637068,"eighty":-5.918058,"marketCap":1633080673},{"date":"2026-02-13","current":-8.89399,"twenty":-13.217763,"median":-8.637068,"eighty":-5.918058,"marketCap":1727921476},{"date":"2026-02-20","current":-9.442084,"twenty":-13.195802,"median":-8.637068,"eighty":-5.918058,"marketCap":1818864712},{"date":"2026-02-27","current":-9.418754,"twenty":-13.077142,"median":-8.637068,"eighty":-5.918058,"marketCap":1818864712},{"date":"2026-03-06","current":-8.866459,"twenty":-13.050618,"median":-8.637068,"eighty":-5.918058,"marketCap":1678552291},{"date":"2026-03-13","current":-9.080009,"twenty":-12.99028,"median":-8.637068,"eighty":-5.918058,"marketCap":1713630396},{"date":"2026-03-20","current":-8.989812,"twenty":-12.872607,"median":-8.637068,"eighty":-5.918058,"marketCap":1697390533},{"date":"2026-03-27","current":-9.422218,"twenty":-12.835328,"median":-8.637068,"eighty":-5.918058,"marketCap":1779239445},{"date":"2026-04-02","current":-10.121514,"twenty":-12.76463,"median":-8.637068,"eighty":-5.918058,"marketCap":1913055920},{"date":"2026-04-10","current":-8.614145,"twenty":-12.646197,"median":-8.634183,"eighty":-5.918058,"marketCap":1770589741},{"date":"2026-04-17","current":-9.098299,"twenty":-12.580967,"median":-8.627645,"eighty":-5.918058,"marketCap":1882437117},{"date":"2026-04-24","current":-8.672978,"twenty":-12.531366,"median":-8.627645,"eighty":-5.918058,"marketCap":1784979462},{"date":"2026-05-01","current":-9.840216,"twenty":-12.408666,"median":-8.627645,"eighty":-5.918058,"marketCap":2028296560},{"date":"2026-05-08","current":-9.387238,"twenty":-12.372989,"median":-8.627645,"eighty":-5.918058,"marketCap":1941304156},{"date":"2026-05-15","current":-10.205734,"twenty":-12.288471,"median":-8.627645,"eighty":-5.918058,"marketCap":2008020135},{"date":"2026-05-22","current":-10.228389,"twenty":-12.254036,"median":-8.627645,"eighty":-5.918058,"marketCap":1997554883},{"date":"2026-05-29","current":-10.59007,"twenty":-12.233824,"median":-8.622406,"eighty":-5.917765,"marketCap":2080240286},{"date":"2026-06-05","current":-11.245266,"twenty":-12.202715,"median":-8.627645,"eighty":-5.918058,"marketCap":2203549908},{"date":"2026-06-12","current":-11.54906,"twenty":-12.154142,"median":-8.627645,"eighty":-5.918058,"marketCap":2243259786},{"date":"2026-06-18","current":-12.068208,"twenty":-12.129758,"median":-8.627645,"eighty":-5.918058,"marketCap":2334681645},{"date":"2026-06-26","current":-12.126491,"twenty":-12.093842,"median":-8.622406,"eighty":-5.917765,"marketCap":2326994875},{"date":"2026-07-02","current":-12.298451,"twenty":-12.093842,"median":-8.622406,"eighty":-5.917765,"marketCap":2372416697},{"date":"2026-07-10","current":-13.041486,"twenty":-12.086912,"median":-8.622406,"eighty":-5.917765,"marketCap":2512874946},{"date":"2026-07-17","current":-12.197585,"twenty":-12.086912,"median":-8.622406,"eighty":-5.917765,"marketCap":2352151577},{"date":"2026-07-24","current":-12.127093,"twenty":-12.086912,"median":-8.622406,"eighty":-5.917765,"marketCap":2324199686},{"date":"2026-07-31","current":-12.200057,"twenty":-12.075175,"median":-8.622235,"eighty":-5.917471,"marketCap":2367525116},{"date":"2026-08-07","current":-12.393886,"twenty":-12.081578,"median":-8.622235,"eighty":-5.917471,"marketCap":2407356560},{"date":"2026-08-14","current":-12.119292,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"marketCap":2389761384},{"date":"2026-08-21","current":-12.797528,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"marketCap":2554741973},{"date":"2026-08-28","current":-13.045486,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"marketCap":2597566722}],"updateTime":1788250493339},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHVS\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634237926","title":"Press Release: Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2634237926","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634237926?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:15","pubTimestamp":1778530500,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, May 11, 2026  -- Pharvaris N.V. , a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema  and acquired angioedema due to C1 inhibitor deficiency , today announced the closing of its previously announced underwritten offering of 4,455,863 ordinary shares . The gross proceeds to Pharvaris from the offering, before deducting underwriting discounts, commissions and other offering expenses, were approximately $132.3 million. All shares in the offering were sold by Pharvaris.Morgan Stanley, Leerink Partners, Cantor, and Wells Fargo Securities acted as joint book-running managers for the offering.Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs in bradykinin-mediated conditions, including all types of bradykinin-mediated angioedema. Pharvar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","LU1548497426.USD","PHVS","IE00BKVL7J92.USD","LU1720051108.HKD","LU0106831901.USD","BK4534","LU1244550221.USD","BK4099","LU1244550494.USD","LU2133065610.SGD","LU2271345857.HKD","LU0912757837.SGD","LU2028103732.USD","LU2023251221.USD","LU1791710582.SGD","LU1732800096.USD","LU2089284900.SGD","LU0267386448.USD","LU1064131342.USD","LU2347655156.SGD","BK4504","LU0882574139.USD","LU1988902786.USD","LU1074936037.SGD","LU0234570918.USD","LU0158827781.USD","LU1732799900.SGD","LU1162221912.USD","LU0106261372.USD","TM","LU1989772840.SGD","LU0971096721.USD","BK4585","BK4516","LU2111349929.HKD","BK4555","LU0557290698.USD","LU1244550577.SGD","LU1989772923.USD","BK4581","LU0158827948.USD","LU1363072403.SGD","LU1668664300.SGD","LU1791710400.SGD","LU2357305700.SGD","BK4604","BK4127","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634142887","title":"Pharvaris price target raised to $31 from $30 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2634142887","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634142887?lang=en_us&edition=fundamental","pubTime":"2026-05-10 22:35","pubTimestamp":1778423705,"startTime":"0","endTime":"0","summary":"BofA analyst Tazeen Ahmad raised the firm’s price target on Pharvaris (PHVS) to $31 from $30 and keeps a Neutral rating on the shares. The firm upd...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharvaris-price-target-raised-to-31-from-30-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharvaris-price-target-raised-to-31-from-30-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634440448","title":"Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634440448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634440448?lang=en_us&edition=fundamental","pubTime":"2026-05-10 21:50","pubTimestamp":1778421041,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-bioage-labs-inc-bioa-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-bioage-labs-inc-bioa-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","AMLX","LU0029874061.USD","BK4137","XLV","PHVS","BK4007","BK4581","BK4585","LABU","XBI","LU0128526141.USD","HCSG","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633345454","title":"BRIEF-Pharvaris Announces Pricing Of $115 Million Underwritten Offering Of Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633345454","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633345454?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:02","pubTimestamp":1778234543,"startTime":"0","endTime":"0","summary":"BRIEF-Pharvaris Announces Pricing Of $115 Million Underwritten Offering Of Ordinary SharesMay 8 (Reuters) - Pharvaris NV PHVS.O:PHARVARIS ANNOUNCES PRICING OF $115 MILLION UNDERWRITTEN OFFERING OF ORD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nFWN41L07W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633434351","title":"Pharvaris prices $115 million follow-on offering at $29.68 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2633434351","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633434351?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:00","pubTimestamp":1778234433,"startTime":"0","endTime":"0","summary":"Pharvaris priced an underwritten follow-on offering of 3,874,664 ordinary shares at USD 29.68 per share.Gross proceeds expected at about USD 115 million before fees, excluding any exercise of underwriters’ option.Underwriters hold 30-day option to buy up to 581,199 additional ordinary shares at offering price, less discounts and commissions.Closing expected on or about May 11, 2026, subject to customary conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL346lCX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014021.USD","IE00BN0W2W23.USD","BK4007","SG9999014039.USD","IE00BKPKM429.USD","NDAQ","PHVS","IE00BGHQF748.EUR","BK4585","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","BK4588","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633434332","title":"Pharvaris Nv: Pricing of an Underwritten Offering of 3,874,664 of Its Ordinary Shares at a Price of $29.68 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2633434332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633434332?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:00","pubTimestamp":1778234412,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nFWN41L07W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633434282","title":"Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633434282","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633434282?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:00","pubTimestamp":1778234400,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, May  08, 2026 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/08/3290920/0/en/Pharvaris-Announces-Pricing-of-115-Million-Underwritten-Offering-of-Ordinary-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1988902786.USD","LU0106831901.USD","LU0971096721.USD","BK4534","LU1244550221.USD","LU1064131342.USD","LU1244550577.SGD","LU1989772923.USD","LU1162221912.USD","LU1791710400.SGD","LU2347655156.SGD","LU1363072403.SGD","IE00BKVL7J92.USD","LU0557290698.USD","LU2133065610.SGD","LU0912757837.SGD","LU2089283258.USD","LU0158827781.USD","BK4581","LU0795875169.SGD","PHVS","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU0006306889.USD","LU0267386448.USD","LU1732800096.USD","BK4007","LU1244550494.USD","LU0795875086.SGD","LU2271345857.HKD","LU0158827948.USD","LU2028103732.USD","BK4588","LU0225283273.USD","LU1720051108.HKD","LU0234570918.USD","LU2023251221.USD","BK4504","LU0098860793.USD","LU1732799900.SGD","LU0106261372.USD","LU0882574139.USD","LU1720051017.SGD","LU2111349929.HKD","LU0320765646.SGD","LU1791710582.SGD","LU2089284900.SGD","LU2357305700.SGD","LU1668664300.SGD","LU0528227936.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925807","title":"Pharvaris CMO Lu Peng disposes of shares worth $427,111.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925807","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925807?lang=en_us&edition=fundamental","pubTime":"2026-05-06 03:52","pubTimestamp":1778010720,"startTime":"0","endTime":"0","summary":"Pharvaris Chief Medical Officer Peng Lu reported selling 14,166 common shares on May 1, 2026 in a scheduled Rule 10b5-1 plan transaction tied to an option exercise.Sale prices were USD 30.16 for 14,023 shares, based on a weighted average across trades, plus USD 31 for 143 shares.Lu also reported acquiring 14,166 shares at USD 2.59 via option exercise.Directly owned common shares fell to 66,083 following transactions.Stock options beneficially owned were reported at 205,308 shares following exercises.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL83c0jL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pharvaris CMO Lu Peng disposes of shares worth $427,111.81","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632862578","title":"Pharvaris Chief Early Development Anne Lesage disposes of shares worth $1.32 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632862578","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632862578?lang=en_us&edition=fundamental","pubTime":"2026-05-02 07:31","pubTimestamp":1777678288,"startTime":"0","endTime":"0","summary":"Pharvaris Chief Early Development Anne Lesage sold 25,400 shares April 29-30.Lesage also exercised options for 25,400 shares at USD 2.59-8.05.Directly held common stock ended unchanged at 56,450 shares.GrayMatters Consulting BV, controlled by Lesage, cut its stake to 133,969 shares from 156,869.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL7F7NMS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pharvaris Chief Early Development Anne Lesage disposes of shares worth $1.32 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630197503","title":"Pharvaris (PHVS) Valuation Check After Conference Data Support For Deucrictibant Combination Regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2630197503","media":"Simply Wall St.","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630197503?lang=en_us&edition=fundamental","pubTime":"2026-04-28 01:09","pubTimestamp":1777309778,"startTime":"0","endTime":"0","summary":"Pharvaris (NasdaqGS:PHVS) is back in focus after new conference data supported the safety of combining its deucrictibant extended release tablet for prophylaxis with immediate release capsules for treating hereditary angioedema breakthrough attacks.\nSee our latest analysis for Pharvaris.\nThe latest conference data seems to have kept interest in Pharvaris alive, with a 1-year total shareholder return of 67.82% and a 3-year total shareholder return above 2x. At the same time, the 90-day share...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/pharvaris-phvs-valuation-check-after-conference-data-support","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/pharvaris-phvs-valuation-check-after-conference-data-support","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DCF","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630879582","title":"Top Pharvaris Executive Executes Notable Insider Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2630879582","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630879582?lang=en_us&edition=fundamental","pubTime":"2026-04-25 10:01","pubTimestamp":1777082497,"startTime":"0","endTime":"0","summary":"New insider activity at Pharvaris ( ($PHVS) ) has taken place on April 24, 2026. Chief Early Development Officer Anne Lesage has cashed out part of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-pharvaris-executive-executes-notable-insider-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-pharvaris-executive-executes-notable-insider-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630821457","title":"Pharvaris director Johannes Schikan disposes 7,100 shares for $213,678.70","url":"https://stock-news.laohu8.com/highlight/detail?id=2630821457","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630821457?lang=en_us&edition=fundamental","pubTime":"2026-04-25 02:10","pubTimestamp":1777054209,"startTime":"0","endTime":"0","summary":"Pharvaris director Johannes Gerardus Christiaan Petrus Schikan sold 7,100 common shares on April 22-23.Sales priced at USD 30.05 on April 22, USD 30.03 on April 23.Schikan held 388,067 Pharvaris common shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL8b2hym:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630182656","title":"Pharvaris Chief Early Development Anne Lesage disposes of USD 225,511 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2630182656","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630182656?lang=en_us&edition=fundamental","pubTime":"2026-04-25 00:18","pubTimestamp":1777047526,"startTime":"0","endTime":"0","summary":"Pharvaris Chief Early Development Anne Lesage sold 7,600 shares on April 22-23 at about $30 per share.Lesage exercised options for 7,600 shares at $2.59-$8.05 in transactions tied to a 10b5-1 trading plan.Directly held common stock fell to 56,450 shares following the trades.GrayMatters Consulting B.V. sold 7,100 shares at about $30, leaving 156,869 shares held indirectly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLb2WgSn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629823268","title":"Pharvaris Chief Medical Officer Lu Peng disposes of common shares worth $213,411","url":"https://stock-news.laohu8.com/highlight/detail?id=2629823268","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629823268?lang=en_us&edition=fundamental","pubTime":"2026-04-24 23:27","pubTimestamp":1777044469,"startTime":"0","endTime":"0","summary":"Pharvaris Chief Medical Officer Lu Peng sold 7,101 common shares on April 22-23.Peng exercised stock options for 7,101 shares at USD 2.59 per share in scheduled transactions under a Rule 10b5-1 plan.Directly held common shares fell to 66,083 following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL5Bk8Jl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pharvaris Chief Medical Officer Lu Peng disposes of common shares worth $213,411","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629080052","title":"Is Evidence Backing Dual Deucrictibant Use Altering The Investment Case For Pharvaris (PHVS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629080052","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629080052?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:08","pubTimestamp":1776766089,"startTime":"0","endTime":"0","summary":"Pharvaris recently presented data at the April 17–19, 2026 Consortium of Independent Immunology Clinics conference showing that combining deucrictibant extended-release tablets for prophylaxis with immediate-release capsules for breakthrough hereditary angioedema attacks is supported by evidence of adequate safety margins.\nAn additional post-hoc analysis comparing icatibant-treated breakthrough attacks in both placebo and deucrictibant arms offers early insight into how pairing a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/is-evidence-backing-dual-deucrictibant-use-altering-the-inve","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/is-evidence-backing-dual-deucrictibant-use-altering-the-inve","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628274786","title":"Pharvaris presents data from deucrictibant IR capsule and XR tablet study","url":"https://stock-news.laohu8.com/highlight/detail?id=2628274786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628274786?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:04","pubTimestamp":1776683090,"startTime":"0","endTime":"0","summary":"Pharvaris (PHVS) presented data evaluating safety margins of administration of deucrictibant immediate-release, or IR, capsule in combination with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharvaris-presents-data-from-deucrictibant-ir-capsule-and-xr-tablet-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharvaris-presents-data-from-deucrictibant-ir-capsule-and-xr-tablet-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863902.USD","BK4161","BK4007","IR","LU0417517546.SGD","LU1978683503.SGD","BK4585","LU0124384867.USD","LU0256863811.USD","PHVS","SG9999001440.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628744212","title":"Pharvaris data support combining deucrictibant XR prophylaxis with IR dosing for breakthrough attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2628744212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628744212?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:50","pubTimestamp":1776682231,"startTime":"0","endTime":"0","summary":"Pharvaris presented analysis at CIIC Spring 2026 Conference on April 17-19 supporting combined use of deucrictibant extended-release for prophylaxis with immediate-release capsules for breakthrough hereditary angioedema attacks.Safety review indicated anticipated dosing scenarios have adequate safety margins, supporting a single-mechanism approach for both prevention and on-demand treatment.Separate post-hoc analysis from CHAPTER-1 provided initial evidence that adding on-demand bradykinin B2 receptor antagonist treatment to prophylaxis can still control breakthrough attacks.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL7j1Lk5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","IE00BN0W2W23.USD","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","PHVS","BK4588","LU2210149790.SGD","BK4585","BK4007","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627423789","title":"Pharvaris price target raised to $52 from $48 at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2627423789","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627423789?lang=en_us&edition=fundamental","pubTime":"2026-04-16 03:40","pubTimestamp":1776282056,"startTime":"0","endTime":"0","summary":"JonesResearch analyst Debanjana Chatterjee raised the firm’s price target on Pharvaris (PHVS) to $52 from $48 and keeps a Buy rating on the shares,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharvaris-price-target-raised-to-52-from-48-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharvaris-price-target-raised-to-52-from-48-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626131881","title":"Pharvaris Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2626131881","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626131881?lang=en_us&edition=fundamental","pubTime":"2026-04-10 00:26","pubTimestamp":1775751960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHVS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 09, 2026 12:26 ET (16:26 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625490319","title":"Morgan Stanley Sticks to Their Buy Rating for Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625490319","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625490319?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:35","pubTimestamp":1775651723,"startTime":"0","endTime":"0","summary":"In a report released today, Maxwell Skor from Morgan Stanley maintained a Buy rating on Pharvaris, with a price target of $41.00. Skor covers the H...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-pharvaris-phvs-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-pharvaris-phvs-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":114,"code":"91000000","status":"200"}]}}